MIST | Milestone Pharmaceuticals Inc
Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: 175.35M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 17, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 17, 2023 March 29, 2023 -0.31 / -0.343.5M / 1.17MBeat! March 14, 2023 - / -0.34- / 1.17MNovember 10, 2022 -0.34 / -0.4081.5M / -Beat! August 10, 2022 -0.39 / -0.36- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 17, 2022 6.500 6.780 6.910
6.470
164.56K -5.25% Aug 16, 2022 6.860 7.034 7.120
6.710
438.23K -3.38% Aug 15, 2022 7.100 6.925 7.120
6.895
39.21K 0.28% Aug 12, 2022 7.080 6.945 7.210
6.690
112.97K 1.43% Aug 11, 2022 6.980 6.750 7.350
6.600
375.28K 7.88% Aug 10, 2022 6.470 6.871 6.950
6.330
202.92K -4.01% Aug 9, 2022 6.740 6.860 6.874
6.530
209.08K -0.3% Aug 8, 2022 6.760 7.025 7.070
6.510
52.40K -1.89% Aug 5, 2022 6.890 6.900 6.974
6.710
130.33K 1.32% Aug 4, 2022 6.800 7.010 7.100
6.720
184.89K -2.16% view more
News
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update finance.yahoo.com Jun 21, 2023 5:32 pm
Milestone Pharmaceuticals Announces First Patient Enrolled in the ReVeRA Study, its Phase 2 Trial of Etripamil in Atrial Fibrillation and Rapid Ventricular Rate finance.yahoo.com Jun 21, 2023 5:30 pm
Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update finance.yahoo.com Jun 21, 2023 4:15 pm
Investors in Milestone Pharmaceuticals (NASDAQ:MIST) have made a respectable return of 36% over the past year finance.yahoo.com Jun 21, 2023 10:20 am
Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation of NODE-301 Data at ACC.21 finance.yahoo.com Jun 21, 2023 7:02 am
Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update finance.yahoo.com Jun 21, 2023 7:01 am
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals: Q1 Earnings Snapshot finance.yahoo.com May 11, 2023 7:31 am
Milestone Pharmaceuticals' (NASDAQ:MIST) investors will be pleased with their decent 75% return over the last three years finance.yahoo.com Apr 21, 2023 9:23 am
Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's Why finance.yahoo.com Jan 16, 2023 12:00 pm
Here's Why Milestone Pharmaceuticals (MIST) is Poised for a Turnaround After Losing 14.5% in 4 Weeks finance.yahoo.com Dec 13, 2022 9:35 am Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5M seekingalpha.com Nov 10, 2022 10:10 pm
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update finance.yahoo.com Jun 21, 2023 7:20 am
Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of PSVT finance.yahoo.com Jun 21, 2023 7:00 am
Milestone Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference finance.yahoo.com Jun 21, 2023 7:00 am Talk about Milestone Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.milestonepharma.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!